Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

AL721, a novel membrane fluidizer.

L Antonian1, M Shinitzky, D Samuel

  • 1Matrix Research Laboratories, Inc., Fort Lee, NJ 07024.

Neuroscience and Biobehavioral Reviews
|January 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CNS Embryonal Tumor with PLAGL Amplification, a New Tumor in Children and Adolescents: Insights from a Comprehensive MRI Analysis.

AJNR. American journal of neuroradiology·2024
Same author

Intravenous thrombolysis for multi-ethnic Asians with acute ischaemia stroke in Malaysian public primary stroke centres versus acute stroke ready hospitals: Comparison of real-world clinical outcomes.

The Medical journal of Malaysia·2023
Same author

Rehabilitation after proximal interphalangeal joint replacement: A structured review of the literature.

Hand surgery & rehabilitation·2021
Same author

The road map toward an hepatitis C virus-free transplant population.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2018
Same author

Safety of sofosbuvir-based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT study.

Alimentary pharmacology & therapeutics·2018
Same author

Safety of an anti-PD-1 immune checkpoint inhibitor in a liver transplant recipient.

Annals of oncology : official journal of the European Society for Medical Oncology·2018
Same journal

Efficacy of Non-Invasive Brain Stimulation in Alzheimer's Disease: An Umbrella Review of Meta-Analyses.

Neuroscience and biobehavioral reviews·2026
Same journal

Rhythms of interaction - the timescales of social coordination and why they matter.

Neuroscience and biobehavioral reviews·2026
Same journal

Neural Bases of Memory Development: Insights from Magnetic Resonance Imaging.

Neuroscience and biobehavioral reviews·2026
Same journal

Regional Heterogeneity of Brain Insulin Resistance: From Molecular Pathways to Neural Circuits.

Neuroscience and biobehavioral reviews·2026
Same journal

Peripheral nervous system involvement in Parkinson's disease: Peripheral neuropathy, neuromuscular junction dysfunction, and clinical implications.

Neuroscience and biobehavioral reviews·2026
Same journal

Violence on the self: Exploring the intersection of trauma and identity among sexual and gender minorities from a neurobiological and developmental perspective to advance our understanding of PTSD, moral injury, and dissociation symptoms.

Neuroscience and biobehavioral reviews·2026
See all related articles

AL721, a novel lipid mixture, rejuvenates cell membrane function by adjusting cholesterol levels. This therapeutic agent reverses age-related cellular decline, restoring functions like brain serotonin receptor activity and immune response.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Gerontology

Background:

  • Cellular membrane composition and fluidity are critical for physiological function.
  • Aging leads to membrane rigidification, impairing cellular functions and contributing to age-related diseases.
  • Existing therapeutic strategies often fail to address the underlying cellular membrane dysfunction.

Purpose of the Study:

  • To investigate the therapeutic potential of AL721, a novel lipid mixture from egg yolks.
  • To elucidate the mechanism of action of AL721 on cellular membranes.
  • To evaluate the efficacy of AL721 in reversing age-associated cellular dysfunction and related conditions.

Main Methods:

  • AL721 was administered to assess its interaction with various cell membranes.

Related Experiment Videos

  • Cholesterol extraction and exchange mechanisms were studied to understand AL721's effect on membrane fluidity.
  • In vitro and in vivo models were used to evaluate functional restoration in aged cells, including brain serotonin receptor function and lymphocyte responsiveness.

    • Main Results:

    • AL721 effectively modifies cellular membrane composition and fluidity by altering cholesterol levels.
    • Physiological functions diminished by membrane rigidification were reversed by AL721 treatment.
    • Restored brain serotonin receptor function and enhanced immune responsiveness in aged subjects were observed.

    Conclusions:

    • AL721 demonstrates significant potential as a therapeutic agent by fluidizing aged cell membranes.
    • The compound shows promise in addressing age-related functional decline, drug tolerance, and potentially viral infections like HIV.
    • Extensive safety studies confirm the non-toxic nature of AL721 in both animal and human subjects.